Pall® Freeze & Go Solutions Protected by RoSS* Technology

Some combinations are so strong it's simply genius. But when you combine Pall's end-to-end support and class-leading Allegro™ biocontainers with RoSS technology - that's cryogenius.

 

Discover a new one-stop solution for the frozen storage and transport of your drug substance that’s safe, protected, supported and tailored to your process. 

 

See a work of cryogenius!

 

You will learn: 

  • How Freeze & Go Solutions can minimize product loss between bulk filling and final filling production steps
  • The cost and product quality benefits of controlled freezing in single-use biocontainers
  • How comprehensive extractables and leachables and transport validation packages contribute to a one-stop solution

Speaker

Speaker Picture

Claire Jarmey-Swan

Global Product Manager, Pall Corporation

Biography

Speaker Picture

David Rigterink

 

Freeze/Transport & Thaw Platforms Specialist, Pall Corporation

Speaker Picture

Johannes Kirchmair

 

Co-founder and CEO, Single Use Support GmbH

Speaker Picture

Patrick Evrard

 

 Senior Principal Engineer, Pall Corporation

Speaker Picture

Peter Black

 

R&D Engineer II, Pall Corporation

Book Your Virtual Freeze & Go Seminar Today!

 

 

Discover more by booking an in-depth seminar customized to your needs including a virtual facility tour.​ Join our experts and learn more how Pall Freeze & Go Solutions protect against leakages and product loss. 

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
May 2021
Overcome Exosome Production Challenges

Biotech | Pall Corporation webinar series

This webinar was recorded by BioPharma Asia and first published on their website. https://biopharma-asia.com. It is made available here by kind permission of BioPharma Asia and the presenters.

 

Hailed as the “next frontier” in cell therapy and regenerative medicine, exosomes are a type of extracellular vesicle and play a key role in the regulation of the intercellular communication processes.

David Haylock of VivaZome will present on upstream production of angiogenic exosomes using the iCELLis® nano fixed bed bioreactor. This will be followed by a presentation by Roberto Ciboldi of Pall Corporation on a platform solution including cell culture, purification and sterile filtration of exosomes.

Participants will be able to:

 

  • Compare the performance of the iCELLis Nano bioreactor to traditional flasks for exosome production from adherent cell culture
  • Understand how an integrated end to end platform delivers highly   purified and consistently-sized exosomes
  • Discover an innovative cGMP scalable manufacturing platform for   exosomes
Watch